Skip to main content

MYOSITIS COMMUNITY PROPOSES A FRAMEWORK TO GUIDE CLINICAL TRIALS AND ENSURE PATIENT SAFETY DURING INFLUX OF CAR-BASED THERAPIES

Publication ,  Conference
Saketkoo, LA; Cheng, K; de Groot, I; de Visser, M; Shenoi, S; Dimachkie, M; Gilkeson, G; Werth, VP; Day, J; Paul, J; Chandwar, KA; Gono, T ...
Published in: ANNALS OF THE RHEUMATIC DISEASES
2025

Duke Scholars

Published In

ANNALS OF THE RHEUMATIC DISEASES

DOI

EISSN

1468-2060

ISSN

0003-4967

Publication Date

2025

Volume

84

Related Subject Headings

  • Arthritis & Rheumatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
  • 1107 Immunology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Saketkoo, L. A., Cheng, K., de Groot, I., de Visser, M., Shenoi, S., Dimachkie, M., … Machado, P. (2025). MYOSITIS COMMUNITY PROPOSES A FRAMEWORK TO GUIDE CLINICAL TRIALS AND ENSURE PATIENT SAFETY DURING INFLUX OF CAR-BASED THERAPIES. In ANNALS OF THE RHEUMATIC DISEASES (Vol. 84). https://doi.org/10.1136/annrheumdis-2025-eular.B1260
Saketkoo, L. A., K. Cheng, I. de Groot, M. de Visser, S. Shenoi, M. Dimachkie, G. Gilkeson, et al. “MYOSITIS COMMUNITY PROPOSES A FRAMEWORK TO GUIDE CLINICAL TRIALS AND ENSURE PATIENT SAFETY DURING INFLUX OF CAR-BASED THERAPIES.” In ANNALS OF THE RHEUMATIC DISEASES, Vol. 84, 2025. https://doi.org/10.1136/annrheumdis-2025-eular.B1260.
Saketkoo LA, Cheng K, de Groot I, de Visser M, Shenoi S, Dimachkie M, et al. MYOSITIS COMMUNITY PROPOSES A FRAMEWORK TO GUIDE CLINICAL TRIALS AND ENSURE PATIENT SAFETY DURING INFLUX OF CAR-BASED THERAPIES. In: ANNALS OF THE RHEUMATIC DISEASES. 2025.
Saketkoo, L. A., et al. “MYOSITIS COMMUNITY PROPOSES A FRAMEWORK TO GUIDE CLINICAL TRIALS AND ENSURE PATIENT SAFETY DURING INFLUX OF CAR-BASED THERAPIES.” ANNALS OF THE RHEUMATIC DISEASES, vol. 84, 2025. Wos-lite, doi:10.1136/annrheumdis-2025-eular.B1260.
Saketkoo LA, Cheng K, de Groot I, de Visser M, Shenoi S, Dimachkie M, Gilkeson G, Werth VP, Day J, Paul J, Chandwar KA, Gono T, Gupta L, Paik J, Vegara AV, Muehlensiepen F, Naddaf E, Ernste FC, Albayda J, Basharat P, Alexanderson H, Shafranski B, Highland K, Stine LC, Venerito V, Kobert L, Galloway C, Oddis CV, Nicolai R, Koopman J, Marrani E, So H, Andrews J, von Muhlen C, Khojah A, Mirza R, Vignesh P, Huber A, Dourado E, Giannini M, Kuwana M, Leclair V, Chung L, Zubair AS, Sanchez J, Tseng CW, Lubinus M, Meyer A, de Araujo DB, Moghadam-Kia S, Yi B, Bader-Meunier B, Sumaila M, Gok F, Ortega LA, Gordon P, Allenzara A, Haemel A, Olsen N, Shaaf M, Gomez R, de Souza JM, Gregory W, Sharma A, Lopez-Corbeto M, Ventura I, Gonzalez N, Papadopoulou C, Bird G, Fornaro M, Vencovsky J, Makowska J, Benitez A, Fernandez A, O’Connor S, Groener M, Dihkan A, Lowe C, Machado P. MYOSITIS COMMUNITY PROPOSES A FRAMEWORK TO GUIDE CLINICAL TRIALS AND ENSURE PATIENT SAFETY DURING INFLUX OF CAR-BASED THERAPIES. ANNALS OF THE RHEUMATIC DISEASES. 2025.

Published In

ANNALS OF THE RHEUMATIC DISEASES

DOI

EISSN

1468-2060

ISSN

0003-4967

Publication Date

2025

Volume

84

Related Subject Headings

  • Arthritis & Rheumatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
  • 1107 Immunology
  • 1103 Clinical Sciences